Ȩ > ±Û·Î¹úÆÄÆ®³Ê > FirstWord Group

FirstWord Group

±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀº FirstWord GroupÀÇ Çѱ¹ ÆÄÆ®³ÊÀÔ´Ï´Ù. FirstWord Group°¡ ¹ßÇàÇÏ´Â ½ÃÀå º¸°í¼­¸¦ ÆÇ¸ÅÇϰí ÀÖ½À´Ï´Ù.
°Ë»öµÇÁö ¾Ê´Â ÀÚ·áµµ ÁÖ¹® °¡´ÉÇÏ´Ï ¹®ÀÇÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
FirstWord ´Â Á¦¾à ¹× ÀÇ·á ±â¼ú ±â¾÷ÀÇ ÀÇ»ç°áÁ¤¿¡ µµ¿òÀÌ µÇ´Â °í°´ÀÇ Á¦Ç°, °æÀï»ç ¹× ½ÃÀå¿¡ °üÇÑ ÇʼöÀûÀÎ Á¤º¸¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀ庸°í¼­¿Í ¿¬°£¼­ºñ½ºÀÇ ÁÖ¿ä Àü¹® Á¶»ç ºÐ¾ß´Â ¹ÙÀÌ¿À½Ã¹Ð·¯, ½ÃÀå Á¢±Ù, ÀÇ·á »ç°Ç, Á¦¾àȸ»ç ¿µ¾÷ ¸¶ÄÉÆÃ, ±â¼ú ¹× Ä¡·á ºÐ¾ß ÀÔ´Ï´Ù. Àü¹®°¡ÀûÀÎ »ç°í¿Í Æø³ÐÀº ÀÎÅÚ¸®Àü½º·Î °¢ ±â¾÷ÀÇ ÁÖ¿ä ºñÁî´Ï½º ÀÇ»ç°áÁ¤À» µ½´Â ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
°Ë»ö
Á¦¸ñ°Ë»ö
1 - 25 ¸®ºä (Àüü£º 57 °Ç) Á¤·Ä Ç¥½Ã °Ç¼ö
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1699593
¹ßÇàÀÏ
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1697014
¹ßÇàÀÏ
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Redefining Medical Affairs: Strategic Shifts and Emerging Priorities Post-Pandemic
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1699594
¹ßÇàÀÏ
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1697015
¹ßÇàÀÏ
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
NPS+ (Europe) - Psoriasis
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1699595
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Medical Affairs Reputations (US) - Targeted Therapies in Severe Asthma (Biologics)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1694051
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
KOL Insight - Wet Age-related Macular Degeneration
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1694049
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1689602
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682220
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Harnessing Real-World Evidence: Best Practices for Medical Affairs Teams
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682221
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Harnessing the Power of Predictive Analytics: The Next Frontier in Pharma Sales Strategies
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682222
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1689603
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Medical Affairs Reputations (US) - Prostate Cancer
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682218
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
KOL Insight - Head and Neck Squamous Cell Carcinoma
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682207
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682206
¹ßÇàÀÏ
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682212
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682208
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682209
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
NPS+ (US) - Targeted Therapies in Severe Asthma (Biologics)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1684123
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Expert Q&A: Virtually In-Person - Enhancing Online Advisory Boards for Peak KOL Engagement
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1684124
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Making a Difference in Rare Diseases: Optimising KOL Identification and Engagement
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682223
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682210
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 39,950 -> £Ü 57,699,000 (ºÎ°¡¼¼ º°µµ)
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1682214
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Medical Affairs Reputations (Europe) - Psoriasis
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1684125
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
Medical Affairs Reputations (US) - Psoriasis
¸®¼­Ä¡»ç
FirstWord Group
»óǰÄÚµå
1684126
¹ßÇàÀÏ
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
 Image  AI ¹ø¿ª ¼­ºñ½º ¹«·á Á¦°ø
°¡°Ý
US $ 8,000 -> £Ü 11,554,000 (ºÎ°¡¼¼ º°µµ)
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦